1. Medtech Insight
  2. >>Geography
  3. >>Europe

EU Ups Funding For Pandemic R&D, Parliament Backs ‘Strategic Autonomy’ In Medical Product Development

 
• By Ian Schofield

With the latest round of discussions on a proposed global pandemic treaty starting this week, one law firm explains how the treaty’s plans for pathogen access and benefit sharing will directly affect many companies developing pandemic products.

3d rendering Virus bacteria cells background
Infectious diseases pose a constant threat • Source: Shutterstock

The World Health Organization may well have announced the end of the emergency phase of the COVID-19 pandemic, and there has been a more or less steady decline in cases at global level, but the virus is still taking its toll.

More than 794,000 new cases and more than 4,800 deaths were reported in the period from 12 June to 9...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By Vibha Sharma

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

European Medtechs Reiterate Opposition To Reciprocal Tariffs On US Imports

 
• By Ashley Yeo

EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 
• By Natasha Barrow

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.

More from Geography